MARKET

RHHBY

RHHBY

Roche Hldg
OTCQX
51.59
-0.29
-0.56%
Closed 15:59 12/31 EST
OPEN
51.65
PREV CLOSE
51.88
HIGH
51.71
LOW
51.45
VOLUME
83.43K
TURNOVER
4.30M
52 WEEK HIGH
52.70
52 WEEK LOW
33.74
MARKET CAP
--
P/E (TTM)
27.89
1D
5D
1M
3M
1Y
5Y
1D
What's Going On With Royalty Pharma Stock Wednesday?
Benzinga · 12/31/2025 15:47
Pfizer, GSK and other drugmakers eying U.S. price hikes for 350 medicines: report
Seeking Alpha · 12/31/2025 13:22
TG Therapeutics: What Wall Street Isn't Telling You
Seeking Alpha · 12/30/2025 16:00
Biogen: Competing With Eli Lilly's Kisunla, Safety Gives Market Edge
Seeking Alpha · 12/30/2025 13:57
Royalty Pharma Acquires Remaining Evrysdi Royalties From PTC Therapeutics
NASDAQ · 12/30/2025 02:15
Royalty Pharma buys remaining royalty interest in Roche drug Evrysdi
Seeking Alpha · 12/29/2025 22:13
Royalty Pharma acquires reaming royalty interest in Evrysdi for $240M upfront
TipRanks · 12/29/2025 21:45
Weekly Report: what happened at RHHBY last week (1222-1226)?
Weekly Report · 12/29/2025 10:33
More
About RHHBY
Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.

Webull offers Roche Holding AG (ADR) stock information, including OTCQX: RHHBY real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RHHBY stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading RHHBY stock methods without spending real money on the virtual paper trading platform.